Multiple Choice Identify the choice that best completes the
statement or answers the question.
|
|
|
1.
|
Executive Summary and Recommendations Naltrexone has been approved as
an adjunct to psychosocial treatment and should not be seen as a replacement for psychosocial
interventions.
|
|
|
2.
|
Patients requiring narcotic analgesia are suitable candidates for naltrexone
treatment.
|
|
|
3.
|
Naltrexone interferes with nonopiod pain medications such as as ibuprofen,
acetaminophen, and aspirin.
|
|
|
4.
|
The Consensus Panel recommends that patients be abstinent for how many days
before initiating naltrexone treatment?
A | 3-7 days | C | 10-20 days | B | 5-10 days | D | 15-30 days |
|
|
|
5.
|
What percent of patients experience adverse effects at the initiation of
naltrexone treatment?
|
|
|
6.
|
Chapter 1 - The Current Situation What percent of the national health
care budget do alcoholics consume?
|
|
|
7.
|
The abuse of alcohol and other substances can cause profound changes in brain
chemistry and function. Understanding of this fact may help to reduce the stigma and shame
surrounding repeated relapse to alcohol abuse.
|
|
|
8.
|
Chapter 2 - Pharmacological Management with Naltrexone When starting a
patient on naltrexone treatment, which of the following should be considered a part of eligibility
determination.
A | Dosing strategies | C | Concurrent psychosocial intervention | B | Medical
considerations | D | All of the
above |
|
|
|
9.
|
Naltrexone has been proven to be an effective replacement to psychosocial
treatment of alcoholism.
|
|
|
10.
|
The daily cost of treatment with naltrexone is approximately:
A | $2.00 per day | C | $6.50 per day | B | $4.50 per day | D | $8.00 per day |
|
|
|
11.
|
Reduction in drinking resulting from treatment combining Naltrexone therapy may
lead to improved liver function.
|
|
|
12.
|
For what drug is Naltrexone contraindicated in patients who are addicted and
have not yet withdrawn?
A | Methamphetamines | C | Marijuana | B | Opiates | D | None of the
above |
|
|
|
13.
|
There is no withdrawal syndrome associated with naltrexone therapy, therefore
the usual daily dose may be discontinued without tapering off.
|
|
|
14.
|
Chapter 3 - Basic Neurobiological and Preclinical Research Advances in
neurobiological research has helped to establish addiction as a biological brain disease that is
relapsing and chronic in nature.
|
|
|
15.
|
The fundamental functional unit of the nervous system is a specialized cell
called a:
A | Macrophage | C | Plasma | B | Neuron | D | Glial |
|
|
|
16.
|
Within a neuron, signals are carried via:
A | Neurotransmitters | C | Electrical Impulses | B | Hormones | D | None of the
above |
|
|
|
17.
|
Chemical messengers that transmit signals between neurons are
neurotransmitters.
|
|
|
18.
|
Pleasure inducing action that becomes repetitive is called:
A | Positive reinforcement | C | Natural reinforcement | B | Negative
reinforcement | D | None of the
above |
|
|
|
19.
|
Unlike many other drugs of abuse (such as opiates, etc.), alcohol acts upon a
specific receptor in the brain.
|
|
|
20.
|
Endogenous opiods, a class of neuropeptides, produce what is know as the
“runner’s high” and also reduce sensitivity to pain.
|
|
|
21.
|
Both animal and human studies have shown alcohol to increase levels of
GABA.
|
|
|
22.
|
This neurotransmitter is the primary inhibitor of the central
nervous system:
A | Dopamine | C | Glutamate | B | Serotonin | D | GABA |
|
|
|
23.
|
Men with alcoholic fathers are how many times more likely than men without any
family history of alcoholism to experience early onset of alcoholism?
A | 3-5 times | C | 10-12 times | B | 5-8times | D | 20-30 times |
|
|
|
24.
|
Chapter 4 - Clinical Findings Naltrexone is the first medication
approved by the FDA for the treatment of alcohol dependence in nearly 50 years.
|
|
|
25.
|
The most impressive result from the studies done with naltrexone were
significantly reduced rates of relapse.
|
|
|
26.
|
The average age of subjects participating in most studies of naltrexone
is:
A | early 30’s | C | late 50’s | B | early 40’s | D | late 20’s |
|
|
|
27.
|
Chapter 5: Clinical Profile Naltrexone was approved by the FDA in
December of:
|
|
|
28.
|
By binding to opiod receptor sites within the central nervous system, naltrexone
prevents the stimulation of opiod receptors.
|
|
|
29.
|
The mean elimination half-life value for naltrexone is:
A | 2 hours | C | 8 hours | B | 6 hours | D | None of the
above |
|
|
|
30.
|
One of the most serious potential adverse effects of naltrexone is kidney
toxicity.
|
In order to issue your certificate, the questions below are required but have a zero point value in the final grade analysis
CEU Certificate
|
|
|
31.
|
Please choose one of the options below for receiving your certificate of CEU’s.
|
Completion Complete each
statement.
|
|
|
32.
|
Please indicate your mailing address or your Fax # if you chose either of these options for receiving your certificate and a contact phone number.
|
|
|
33.
|
If you have one, indicate your licensing organization, license type and # (ex. BBS, MFT#123456). Returning participants may leave this blank.
|
Matching
|
|
|
Please evaluate the course by choosing one of the responses below for each
question. This data will help us to improve our program and meet certifying organization
requirements. Thank you for allowing QUE to be your
provider.
A | Excellent | C | Average | B | Above Average | D | Below Average |
|
|
|
34.
|
The extent to which this course met the objectives
|
|
|
35.
|
The adequacy of the author’s mastery of the subject
|
|
|
36.
|
Efficiency of course mechanics
|
|
|
37.
|
The applicability or usability of the information for you
|
|
|
38.
|
Website functionality and ease of use
|
|
|
39.
|
Availability of course instructors
(does the website provide adequate direction on how to access a staff member or instructor if needed for assistance?)
|
Short Answer
|
|
|
40.
|
Please provide us with any additional comments or suggestions that would help us
to improve the quality of our program:
|
|
|
41.
|
How did you find out about QUE?
NOTE: A warning will appear if there are any questions left blank, including boxes that may not apply to you. Simply ignore the warning box, click yes to submit anyway and allow the program a moment or two to grade your exam.
**After a passing grade is displayed, close the grade window (which will return you to the course page) and proceed to Step #4 to complete the payment process. See Step #5 re: receipt of certification.
In order to maintain the integrity of our online testing program - correct/incorrect answers will not be displayed. Only your final grade is displayed. Good Luck on your exam! |